Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
QuantumLeap Healthcare Collaborative
Eli Lilly and Company
Revolution Medicines, Inc.
AbbVie
Astellas Pharma Inc
Amgen
Gustave Roussy, Cancer Campus, Grand Paris
Weill Medical College of Cornell University
Shandong Cancer Hospital and Institute
University of California, San Diego
The First Affiliated Hospital of Guangzhou Medical University
Nanfang Hospital, Southern Medical University